Category Archives: Public Policy

Latest From Public Policy

Media Coverage of BIO’s Intellectual Property Conference in Seattle

Stanford v. Roche: An Academic/Industry Collaboration Gone Wrong A Landmark Case: The Aftermath of Myriad Genetics Ethical Issues: Staying in the Frying Pan and out of the Fire

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

House Judiciary Committee’s Patent Reform Bill is in Need of Reform, Says BIO

PRESS RELEASE WASHINGTON, D.C. (Friday, April 15, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement regarding the America Invents Act, H.R. 1249, which passed the House Committee on the Judiciary yesterday:   “BIO has consistently praised House Judiciary Committee Chairman Lamar Smith (R-TX) for his introduction of a comprehensive patent reform bill similar to the bill adopted by the U.S. Senate earlier this month by a nearly unanimous vote.  Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , ,

Fabry Patient Law Suit and Request to NIH for March-in Petition Rehearing

An article out of the Genomics Law Report discussing the recent law suit citing violations of the Bayh Dole Act. A second article from Patent Docs discusses the request for rehearing of the patients petition to the NIH for march-in.

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

USPTO Remains Open for Six Business Days if Government Shuts Down

Press Release, 11-26 USPTO Prepares for Possible Government Shutdown In the event of a government shutdown on April 9, 2011, the United States Patent and Trademark Office will remain open and continue to operate as usual for a period of six business days – through Monday, April 18, 2011 — because the USPTO has enough available reserves, not linked to the current fiscal year, to remain in operation until then. Should a shutdown occur and Read More >

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , ,

Myriad Oral Argument Review and Analysis by Patent Docs

Great comprehensive review of oral arguments at the federal circuit in the Myriad case by Kevin Noonan of Patent Docs.

Patently BIOtech  |  1 Comment  |  Email This Post
Tags: , , , , ,